<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
QUADRATECH, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
749 3OY 107
- --------------------------------------------------------------------------------
(CUSIP Number)
Francis J. Rigney, Jr., M.D.
300 N. Baldwin Park Blvd.
City of Industry, California 91746-1405
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
October 1, 1999
- -------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with the statement [ ]. (A
fee is not required only if the reporting person: (1) has a previous statement
on file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1(a) for other parties to whom copies
are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 (``Act'') or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
(Continued on following pages)
Page 1 of 4 pages
<PAGE>
<TABLE>
<CAPTION>
<S> <C>
- ----------------------- ---------------------
CUSIP NO. 749 3OY 107 13D PAGE 2 OF 4
- ----------------------- ---------------------
- ------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Francis J. Rigney, Jr., M.D.
###-##-####
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [_]
(b) [ ]
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 SOURCE OF FUNDS* PF
- ------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) OR 2(e) [ ]
- ------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- ------------------------------------------------------------------------------
7 SOLE VOTING POWER:
NUMBER
3,020,000
OF
-----------------------------------------------------------
SHARES 8 SHARED VOTING POWER:
BENEFICIALLY
OWNED BY -----------------------------------------------------------
9 SOLE DISPOSITIVE POWER:
EACH
3,020,000
REPORTING
-----------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER:
WITH
- ------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,020,000
- ------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
[ ]
- ------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
8.27%
- ------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- ------------------------------------------------------------------------------
</TABLE>
<PAGE>
---------------------
Page 3 of 4
---------------------
Items 1 through 7 to Schedule 13D
- ---------------------------------
Item 1:
(a) Class of securities: Common stock
(b) Name of issuer: Quadratech, Inc.
(c) Address of issuer: 300 N. Baldwin Park Blvd.
City of Industry, CA 91746-1405
Item 2:
(a) Francis J. Rigney, Jr., M.D.
(b) 2605 California Street,
San Francisco, CA 94115
(c) Retired/investor
(d) None
(e) None
(f) USA
Item 3: PF
Item 4:
Purpose of acquisition of securities of issuer: Personal investment in
company that has exceptional products and potential. No other purpose.
Item 5:
(a) 3,020,000 shares owned (8.27%) of 36,573,301 shares issued and
outstanding.
(b) 3,020,000 shares
(c) Transactions during last sixty days were:
On October 1, 1999, Quadratech issued 15,000,000 shares for the
acquisition of Accuchem, which reduced Francis J. Rigney, Jr.'s
percentage of shares outstanding from 14.72% to 8.27% of 36,513,301.
(d) N/A
(e) N/A
Item 6: None
Item 7: None
<PAGE>
---------------------
Page 4 of 4
---------------------
SIGNATURE
---------
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: October 1, 1999
By: /s/ Francis J. Rigney
----------------------------------
Francis J. Rigney, Jr., M.D.
